Nektar TherapeuticsNKTRNASDAQ
Loading
Year-over-year research & development expense growth
Latest
-2.96%
↓ 1245% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
0.26%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -2.96% |
| 2024 | 5.91% |
| 2023 | -47.71% |
| 2022 | -45.46% |
| 2021 | -2.06% |
| 2020 | -5.96% |
| 2019 | 8.77% |
| 2018 | 48.82% |
| 2017 | 31.73% |
| 2016 | 11.50% |